UAMY
ACHAT TOTAL: 62 700 titres (~298 685,00 $ US)
- Insiders
- Bardswich Lloyd, Carrabba Joseph A, Aguirre Blaise A., EVANS GARY C
- Total bought
- $298,685
- Total sold
- —
- Last activity
- 2026-09-01
- Last synced
-
2026-09-07 10:23:47
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Neutral signal Scored 2026-09-04
UAMY presents a meaningful insider cluster buy signal (4 insiders, ~$299k) with a confirmed government catalyst supporting volumes, which justifies attention despite weak antimony prices.
The first sentence of the analysis written for UAMY on 2026-09-04 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | -4.3% | 23.2% | -38.5% | 18.1% | 10.8% | |
| Ebit Margin | -11.1% | -15.9% | -78.8% | 4.2% | -0.7% | |
| Ebitda Margin | -7.9% | -8.7% | -67.8% | 12.4% | 10.7% | |
| Operating Profit Margin | -22.6% | -16.0% | -81.3% | 3.2% | -8.5% | |
| Pretax Profit Margin | -11.1% | -11.6% | -73.0% | 4.0% | -0.8% | |
| Continuous Operations Profit Margin | -11.1% | -11.6% | -73.0% | 3.9% | -0.8% | |
| Net Profit Margin | -11.1% | -11.6% | -73.0% | 3.9% | -0.8% | |
| Bottom Line Profit Margin | -11.1% | -11.6% | -73.1% | 3.5% | -1.4% | |
| Current Ratio | 5.379 | 5.161 | 15.685 | 9.738 | 11.381 | |
| Quick Ratio | 4.148 | 4.850 | 14.140 | 9.119 | 10.872 | |
| Solvency Ratio | -0.239 | -0.107 | -2.094 | 0.473 | 0.311 | |
| Cash Ratio | 2.996 | 4.536 | 13.259 | 8.586 | 10.316 | |
| Price To Earnings Ratio | -142.614 | -110.625 | -4.213 | 135.250 | -452.545 | |
| Price To Earnings Growth Ratio | -1.188 | 1.517 | 0.002 | -0.317 | 4.636 | |
| Forward Price To Earnings Growth Ratio | -1.188 | 1.517 | 0.002 | -0.317 | 4.636 | |
| Price To Earnings Diluted Ratio | -142.614 | -110.625 | -4.213 | 135.250 | -452.545 | |
| Price To Earnings Diluted Growth Ratio | -1.188 | 1.517 | 0.002 | -0.317 | 4.636 | |
| Price To Book Ratio | 4.403 | 6.720 | 1.049 | 1.624 | 1.582 | |
| Price To Sales Ratio | 15.810 | 12.867 | 3.081 | 4.686 | 6.607 | |
| Price To Free Cash Flow Ratio | -16.551 | 107.396 | -4.265 | -26.194 | -16.623 | |
| Price To Operating Cash Flow Ratio | -64.044 | 86.568 | -5.638 | -207.606 | -21.054 | |
| Debt To Assets Ratio | 0.001 | 0.049 | 0.001 | 0.009 | 0.006 | |
| Debt To Equity Ratio | 0.001 | 0.060 | 0.001 | 0.010 | 0.007 | |
| Debt To Capital Ratio | 0.001 | 0.056 | 0.001 | 0.010 | 0.007 | |
| Long Term Debt To Capital Ratio | 0.000 | 0.007 | 0.000 | 0.007 | 0.006 | |
| Financial Leverage Ratio | 1.092 | 1.211 | 1.101 | 1.089 | 1.081 | |
| Working Capital Turnover Ratio | 1.282 | 1.001 | 0.534 | 0.540 | 0.823 | |
| Operating Cash Flow Ratio | -0.952 | 0.554 | -5.293 | -0.112 | -1.174 | |
| Operating Cash Flow Sales Ratio | -0.247 | 0.149 | -0.546 | -0.023 | -0.314 | |
| Free Cash Flow Operating Cash Flow Ratio | 3.870 | 0.806 | 1.322 | 7.926 | 1.267 | |
| Debt Service Coverage Ratio | -18.095 | -1.705 | -207.138 | 12.380 | 44.006 | |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 | 22.997 | -119.201 | |
| Short Term Operating Cash Flow Coverage Ratio | -56.658 | 2.926 | -167.002 | -2.648 | -183.785 | |
| Operating Cash Flow Coverage Ratio | -52.370 | 1.299 | -167.002 | -0.799 | -11.301 | |
| Capital Expenditure Coverage Ratio | -0.348 | 5.156 | -3.107 | -0.144 | -3.752 | |
| Dividend Paid And Capex Coverage Ratio | -0.348 | 5.156 | -2.051 | -0.144 | -3.752 | |
| Dividend Payout Ratio | 0.000 | 0.000 | -0.124 | 0.000 | 0.000 | |
| Enterprise Value Multiple | -190.739 | -135.818 | -2.531 | 24.106 | 36.375 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | -4.3% | ▼-27.6% | ▼-6.2% |
| Ebit Margin | -11.1% | ▲4.9% | ▲9.4% |
| Ebitda Margin | -7.9% | ▲0.8% | ▲4.4% |
| Operating Profit Margin | -22.6% | ▼-6.6% | ▲2.5% |
| Pretax Profit Margin | -11.1% | ▲0.5% | ▲7.4% |
| Continuous Operations Profit Margin | -11.1% | ▲0.5% | ▲7.5% |
| Net Profit Margin | -11.1% | ▲0.5% | ▲7.5% |
| Bottom Line Profit Margin | -11.1% | ▲0.6% | ▲7.7% |
| Current Ratio | 5.379 | ▲0.217 | ▼-4.090 |
| Quick Ratio | 4.149 | ▼-0.702 | ▼-4.477 |
| Solvency Ratio | -0.239 | ▼-0.132 | ▲0.092 |
| Cash Ratio | 2.996 | ▼-1.540 | ▼-4.942 |
| Price To Earnings Ratio | -142.614 | ▼-31.989 | ▼-27.664 |
| Price To Earnings Growth Ratio | -1.188 | ▼-2.705 | ▼-2.119 |
| Forward Price To Earnings Growth Ratio | -1.188 | ▼-2.705 | ▼-2.119 |
| Price To Earnings Diluted Ratio | -142.614 | ▼-31.989 | ▼-27.664 |
| Price To Earnings Diluted Growth Ratio | -1.188 | ▼-2.705 | ▼-2.119 |
| Price To Book Ratio | 4.403 | ▼-2.317 | ▲1.327 |
| Price To Sales Ratio | 15.810 | ▲2.943 | ▲7.199 |
| Price To Free Cash Flow Ratio | -16.551 | ▼-123.947 | ▼-25.303 |
| Price To Operating Cash Flow Ratio | -64.044 | ▼-150.612 | ▼-21.689 |
| Debt To Assets Ratio | 0.001 | ▼-0.048 | ▼-0.012 |
| Debt To Equity Ratio | 0.001 | ▼-0.059 | ▼-0.014 |
| Debt To Capital Ratio | 0.001 | ▼-0.055 | ▼-0.014 |
| Long Term Debt To Capital Ratio | 0.000 | ▼-0.007 | ▼-0.004 |
| Financial Leverage Ratio | 1.092 | ▼-0.119 | ▼-0.023 |
| Working Capital Turnover Ratio | 1.282 | ▲0.281 | ▲0.446 |
| Operating Cash Flow Ratio | -0.952 | ▼-1.506 | ▲0.443 |
| Operating Cash Flow Sales Ratio | -0.247 | ▼-0.396 | ▼-0.051 |
| Free Cash Flow Operating Cash Flow Ratio | 3.869 | ▲3.063 | ▲0.832 |
| Debt Service Coverage Ratio | -18.095 | ▼-16.390 | ▲16.016 |
| Interest Coverage Ratio | 0.000 | 0.000 | ▲19.241 |
| Short Term Operating Cash Flow Coverage Ratio | -56.658 | ▼-59.584 | ▲24.776 |
| Operating Cash Flow Coverage Ratio | -52.370 | ▼-53.669 | ▼-6.335 |
| Capital Expenditure Coverage Ratio | -0.348 | ▼-5.505 | ▲0.091 |
| Dividend Paid And Capex Coverage Ratio | -0.348 | ▼-5.505 | ▼-0.121 |
| Dividend Payout Ratio | 0.000 | 0.000 | ▲0.025 |
| Enterprise Value Multiple | -190.739 | ▼-54.921 | ▼-137.018 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $620.6M | $192.2M | $26.8M | $51.8M | $51.2M | |
| Enterprise value | $590.3M | $175.7M | $14.9M | $33.0M | $30.0M | |
| EV / Sales | 15.04x | 11.77x | 1.72x | 2.99x | 3.88x | |
| EV / Op. cash flow | -60.92x | 79.15x | -3.14x | -132.40x | -12.36x | |
| EV / Free cash flow | -15.74x | 98.20x | -2.38x | -16.70x | -9.76x | |
| EV / EBITDA | -190.74x | -135.82x | -2.53x | 24.11x | 36.38x | |
| Net debt / EBITDA | 9.79x | 12.72x | 2.02x | -13.69x | -25.60x | |
| Current ratio | 5.38x | 5.16x | 15.69x | 9.74x | 11.38x | |
| Income quality | 2.23x | -1.28x | 0.75x | -0.58x | 40.21x | |
| Graham number | — | — | — | $0 | — | |
| Graham net-net | $0 | $0 | $0 | $0 | $0 | |
| Tax burden | 100.0% | 100.0% | 100.0% | 96.4% | 100.0% | |
| Interest burden | 100.0% | 72.7% | 92.7% | 96.7% | 110.1% | |
| Working capital | $44.6M | $16.7M | $13.2M | $19.4M | $21.5M | |
| Invested capital | $87.0M | $30.1M | $26.6M | $31.5M | $32.6M | |
| Return on assets | -2.8% | -5.0% | -22.6% | 1.2% | -0.2% | |
| Operating ROA | -9.4% | -7.6% | -22.5% | 1.0% | -2.7% | |
| Return on tangible assets | -2.8% | -5.0% | -22.6% | 1.2% | -0.2% | |
| Return on equity | -3.1% | -6.1% | -24.9% | 1.3% | -0.2% | |
| Return on invested capital | -6.2% | -7.5% | -26.0% | 1.0% | -2.0% | |
| Return on capital employed | -6.2% | -7.8% | -26.0% | 1.1% | -2.0% | |
| Earnings yield | -0.7% | -0.9% | -23.7% | 0.8% | -0.1% | |
| Free cash flow yield | -6.0% | 0.9% | -23.4% | -3.8% | -6.0% | |
| Capex / Op. cash flow | -287.0% | 19.4% | -32.2% | -692.6% | -26.7% | |
| Capex / Depreciation | 2383.8% | 39.7% | 159.3% | 189.9% | 73.6% | |
| Capex / Sales | 70.8% | 2.9% | 17.6% | 15.6% | 8.4% | |
| SG&A / Sales | 14.0% | 36.0% | 33.6% | 13.1% | 16.0% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 18.0% | 3.8% | 0.0% | 0.6% | 0.6% | |
| Intangibles / Total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Days sales outstanding | 39d | 28d | 26d | 26d | 42d | |
| Days payables outstanding | 62d | 49d | 14d | 25d | 73d | |
| Operating cycle | 151d | 68d | 68d | 81d | 98d | |
| Cash conversion cycle | 89d | 19d | 54d | 56d | 25d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+222.9%EV / Sales ▲+27.8%EV / EBITDA ▼-40.4%EV / Op. cash flow ▼-140.070Earnings yield ▲+0.002
Profitability
Return on equity ▲+0.030Return on assets ▲+0.022Return on invested capital ▲+0.013Return on capital employed ▲+0.016Operating ROA ▼-0.018Income quality ▲+3.516Tax burden 0.000
Efficiency
Days sales outstanding ▲+10.913Days payables outstanding ▲+12.515Operating cycle ▲+82.848Cash conversion cycle ▲+70.333Capex / Sales ▲+0.680R&D / Sales n/a
Balance-sheet strength
Current ratio ▲+0.217Net debt / EBITDA ▼-2.929Working capital ▲+27892666.000Invested capital ▲+56858875.000Intangibles / Total assets n/a
Change over 5 years
Valuation
Market cap ▲+1112.4%EV / Sales ▲+287.8%EV / EBITDA ▼-624.4%EV / Op. cash flow ▼-48.560Earnings yield ▼-0.006
Profitability
Return on equity ▼-0.029Return on assets ▼-0.026Return on invested capital ▼-0.042Return on capital employed ▼-0.042Operating ROA ▼-0.067Income quality ▼-37.977Tax burden 0.000
Efficiency
Days sales outstanding ▼-2.818Days payables outstanding ▼-11.512Operating cycle ▲+52.996Cash conversion cycle ▲+64.508Capex / Sales ▲+0.625R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-6.002Net debt / EBITDA ▲+35.397Working capital ▲+23066708.000Invested capital ▲+54355920.000Intangibles / Total assets n/a
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-09-04 Bank of America Corp DE Has $1.70 Million Holdings in United States Antimony Co. $UAMY Bank of America Corp DE trimmed its holdings in shares of United States Antimony Co. (NYSE: UAMY) by 35.7% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 194,539 shares of the company''s stock after selling 107,972 shares during the period.
- 2026-09-02 United States Antimony Jumps 8%, USA Rare Earth Ticks Up: Is Insider Buying Behind the Move? The critical minerals corner is splitting this morning between a company-specific bid in antimony and a rare earth basket that''s drifting lower. That''s the tell in what looks like an isolated single-name bounce.
- 2026-09-02 United States Antimony: Weak Pricing, Stronger Volumes, And A Government Catalyst United States Antimony is rated Buy, with a $10-11 target, as the market overreacts to weak antimony prices and trailing revenue. Q2 volumes rose 26% YoY despite a 52% drop in realized antimony prices, indicating operational strength masked by commodity headwinds. A $245M government contract is ramping up, with revenue conversion just beginning and significant upside potential as deliveries accelerate.
- 2026-08-30 United States Antimony (NYSE:UAMY) Stock Price Down 5.8% – What’s Next? Shares of United States Antimony Co. (NYSE: UAMY - Get Free Report) traded down 5.8% during trading on Friday. The company traded as low as $4.83 and last traded at $4.86. 2,003,651 shares were traded during trading, a decline of 82% from the average session volume of 11,226,925 shares. The stock had previously closed at
- 2026-08-25 Critical Metals Spikes 19%, MP Materials and United States Antimony Lag: Is the European Lithium Merger Driving the Move? Critical Metals is surging nearly 20% while its rare earth peers sit flat or slide lower, and no company announcement explains the gap. One unverified catalyst keeps surfacing in trader circles, and it has nothing to do with the ground under Greenland.
- 2026-08-25 United States Antimony Provides Update on Mining Success at Stibnite Hill, Montana "The Critical Minerals and ZEO Company" ~ Antimony, Gold, Tungsten, and Zeolite ~ DALLAS, TX / ACCESS Newswire / August 25, 2026 / United States Antimony Corporation ("USAC," "US Antimony," or the "Company"), (NYSE:UAMY)(NYSE Texas:UAMY), a leading producer and processor of antimony, zeolite, and other critical minerals, and the only fully integrated antimony company in the world outside of China and Russia, is pleased to announce the successful continuation of mining operations at its Stibnite Hill property in Thompson Falls, Montana. Since resuming mining operations this past spring in April, USAC has continued to advance its domestic antimony mining program at Stibnite Hill in Montana.
- 2026-08-24 USA Rare Earth Falls 5% Despite $1.55B Government-Backed Funding, United States Antimony Drops 9% Something is definitely going on with critical-mineral stocks today. USA Rare Earth (NASDAQ:USAR) stock is down 5% to $18.26 in Monday midday trading, even after the company cleared a major closing condition for its Serra Verde acquisition with heavy U.S.
- 2026-08-19 United States Antimony Jumps 8% on $100M Buyback, USA Rare Earth Slips, MP Materials Holds Flat United States Antimony (NYSE:UAMY) stock is up 8% midday Wednesday to $5.63 after the board authorized a share repurchase program of up to $100 million.
- 2026-08-19 Why United States Antimony Stock Is Rocketing Higher Today U.S. Antimony stock sank 8% yeesterday. The company has reported negative $20.7 million in cash from operations for the first half of 2026.
- 2026-08-19 United States Antimony Announces $100 Million Share Repurchase Program "The Critical Minerals and ZEO Company" ~ Antimony, Gold, Tungsten, and Zeolite ~ DALLAS, TX / ACCESS Newswire / August 19, 2026 / United States Antimony Corporation ("USAC," "US Antimony," or the "Company"), (NYSE:UAMY)(NYSE Texas:UAMY), a leading producer and processor of antimony, zeolite, and other critical minerals, and the only fully integrated antimony company in the world outside of China and Russia, announced today that the Company''s Board of Directors has approved and authorized a share repurchase program under which the Company may repurchase up to $100 million of its existing and outstanding common stock. Repurchases under the program may be made in the open market, in privately negotiated transactions, or otherwise, with the amount and timing of repurchases to be determined at the discretion of the Company''s Finance Committee as authorized by the Board of Directors, depending on market conditions and corporate needs.